trastuzumabn.

Brit.

/ˌtrɑːˈstuːzuːmab/,

/ˌtraˈstuːzuːmab/, U.S.

/ˌtræˈstuzumæb/

Origin: Formed within English, by compounding. Etymons: English trastuz- , human adj., English monoclonal antibody.

Etymology: < trastuz- (origin unknown) +-u- (in human adj.) + -mab , representing monoclonal antibody ( < monoclonal adj. + antibody n.).

Pharmacology.

A drug consisting of a preparation of humanized monoclonal antibodies directed against a cell surface receptor (human epidermal growth factor receptor 2; Her2) which contributes to the growth of some breast cancers, used in the treatment of such cancers.A proprietary name for this drug is Herceptin.

ΘΚΠ

the world > health and disease > healing > medicines or physic > medicines for specific purpose > preparations treating or preventing specific ailments > [noun] > for cancer or leukemia

amethopterin1948

Myleran1952

Laetrile1953

thioguanine1953

thioTEPA1953

mercaptopurine1954

methotrexate1955

busulfan1956

chlorambucil1956

cyclophosphamide1960

vinblastine1962

vincristine1962

levamisole1969

vinca alkaloid1970

doxorubicin1971

tamoxifen1972

Airol1974

trastuzumab1997

thiotepa-

1997 Business Wire (Nexis) 22 Dec. Genentech, based in South San Francisco, California, Friday announced favorable preliminary results from a Phase III trial of its trastuzumab (Herceptin) anti-HER2 monoclonal antibody in women with metastatic breast cancer who overexpress the HER2 oncogene.

1998 Lancet 10 Oct. 1205/1 On Sept. 25, the US FDA approved the first monoclonal antibody for breast cancer, Genentech's trastuzumab.

2008 Atlantic Monthly July 81/2 Breast-cancer patients with one of the two forms of the gene HER-2 responded differently to the new cancer drug trastuzumab (Herceptin).

This is a new entry (OED Third Edition, November 2010; most recently modified version published online March 2022).

单词	trastuzumab
释义	trastuzumabn. Brit. /ˌtrɑːˈstuːzuːmab/, /ˌtraˈstuːzuːmab/, U.S. /ˌtræˈstuzumæb/ Origin: Formed within English, by compounding. Etymons: English trastuz- , human adj., English monoclonal antibody. Etymology: < trastuz- (origin unknown) +-u- (in human adj.) + -mab , representing monoclonal antibody ( < monoclonal adj. + antibody n.). Pharmacology. A drug consisting of a preparation of humanized monoclonal antibodies directed against a cell surface receptor (human epidermal growth factor receptor 2; Her2) which contributes to the growth of some breast cancers, used in the treatment of such cancers.A proprietary name for this drug is Herceptin. ΘΚΠ the world > health and disease > healing > medicines or physic > medicines for specific purpose > preparations treating or preventing specific ailments > [noun] > for cancer or leukemia amethopterin1948 Myleran1952 Laetrile1953 thioguanine1953 thioTEPA1953 mercaptopurine1954 methotrexate1955 busulfan1956 chlorambucil1956 cyclophosphamide1960 vinblastine1962 vincristine1962 levamisole1969 vinca alkaloid1970 doxorubicin1971 tamoxifen1972 Airol1974 trastuzumab1997 thiotepa- 1997 Business Wire (Nexis) 22 Dec. Genentech, based in South San Francisco, California, Friday announced favorable preliminary results from a Phase III trial of its trastuzumab (Herceptin) anti-HER2 monoclonal antibody in women with metastatic breast cancer who overexpress the HER2 oncogene. 1998 Lancet 10 Oct. 1205/1 On Sept. 25, the US FDA approved the first monoclonal antibody for breast cancer, Genentech's trastuzumab. 2008 Atlantic Monthly July 81/2 Breast-cancer patients with one of the two forms of the gene HER-2 responded differently to the new cancer drug trastuzumab (Herceptin). This is a new entry (OED Third Edition, November 2010; most recently modified version published online March 2022). < n.1997
随便看	malgovernance malgovernment malgrace malgracious malgrado malgré malgré elle malgré eux malgré lui malgré moi malgré tout malheur malheureusement malhygiene mali malian malibu malibu board malic malic acid malice malice aforethought malice forethought malice prepended malice prepense